Research map: Screening for Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Evidence, Challenges, and the Role of Imaging—From the AJR Special Series on Screening

Back to the article

Papers in this map

  1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases · Naga Chalasani · 2017 · 7417 citations · Cited by this paper
  2. Two Clinical Scenarios, One Responsibility: The Radiologist Across the MASLD Spectrum · Marco Dioguardi Burgio · 2026 · Cites this paper
  3. Mammography-Based Deep Learning Model Better Than Breast Density at Predicting Breast Cancer Risk · 2026 · Related
  4. An Algorithm for the Grading of Activity in Chronic Hepatitis C · Pierre Bédossa · 1996 · 4063 citations · Cited by this paper
  5. The Need for a Practical Reporting Framework for Pelvic Venous Findings on Imaging · 2026 · Related
  6. A multisociety Delphi consensus statement on new fatty liver disease nomenclature · Mary Eugenia Rinella · 2023 · 3032 citations · Cited by this paper
  7. Isolated Axillary Lymphadenopathy in Women Without a Known Breast Cancer Diagnosis: A Multicenter Study of Biopsy Outcomes · 2026 · Related
  8. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease · Mary Eugenia Rinella · 2023 · 2555 citations · Cited by this paper
  9. A Multisociety Statement Provides Guidance on Optimizing Radiography Utilization for Low-Yield Anatomic Sites · 2026 · Related
  10. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up · Mattias Ekstedt · 2014 · 2304 citations · Cited by this paper
  11. Clinical Implementation of Opportunistic Screening for Osteoporosis · 2026 · Related
  12. The utility of radiological imaging in nonalcoholic fatty liver disease · Sherif N. Saadeh · 2002 · 2138 citations · Cited by this paper
  13. Vision Language Models for Ultrasound Assessment of Suspicious Axillary Lymph Nodes in Breast Cancer · 2026 · Related
  14. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) · Frank Tacke · 2024 · 2049 citations · Cited by this paper
  15. Artificial Intelligence Is Not a Panacea: LungIMPACT Trial Shows Prioritization Cannot Overcome Systemic Delays in Lung Cancer Diagnosis · 2026 · Related
  16. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis · Stephen A. Harrison · 2024 · 1982 citations · Cited by this paper
  17. The Next Frontier in Coronary CTA: Reliable Coronary Stent Assessment Through Technical Innovation · 2026 · Related
  18. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis · Rubén Hernáez · 2011 · 1602 citations · Cited by this paper
  19. Author Disclosure of Use of Generative Artificial Intelligence Technologies in Submissions to AJR : Reflections From the AJR Editor in Chief · 2026 · Related
  20. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings · Kenneth J. Cusi · 2022 · 1009 citations · Cited by this paper
  21. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis · Stuart McPherson · 2016 · 945 citations · Cited by this paper
  22. Epidemiology of metabolic dysfunction-associated steatotic liver disease · Zobair M. Younossi · 2024 · 876 citations · Cited by this paper
  23. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial · Stephen A. Harrison · 2019 · 798 citations · Cited by this paper
  24. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease · Charlie C. Park · 2016 · 717 citations · Cited by this paper
  25. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement · R. Graham Barr · 2015 · 636 citations · Cited by this paper
  26. Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials · Cyrielle Caussy · 2018 · 577 citations · Cited by this paper
  27. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials · Mazen Noureddin · 2013 · 552 citations · Cited by this paper
  28. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis · Ferenc Emil Mózes · 2021 · 520 citations · Cited by this paper
  29. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study · Rohit Seth Loomba · 2014 · 487 citations · Cited by this paper
  30. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement · R. Graham Barr · 2020 · 476 citations · Cited by this paper
  31. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis · Emmanuel Anandraj Selvaraj · 2021 · 370 citations · Cited by this paper
  32. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice · Parambir Singh Dulai · 2016 · 358 citations · Cited by this paper
  33. Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease · Vincent Wai‐Sun Wong · 2012 · 349 citations · Cited by this paper
  34. Quantification of Liver Fat Content with CT and MRI: State of the Art · Jitka Starekova · 2021 · 319 citations · Cited by this paper
  35. Liver fat imaging—a clinical overview of ultrasound, CT, and MR imaging · Yingzhen N. Zhang · 2018 · 307 citations · Cited by this paper
  36. Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis · Jonathan G. Stine · 2020 · 282 citations · Cited by this paper
  37. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis · Michael S. Middleton · 2017 · 279 citations · Cited by this paper
  38. Value-added Opportunistic CT Screening: State of the Art · Perry J. Pickhardt · 2022 · 242 citations · Cited by this paper
  39. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis · Richard K. Sterling · 2024 · 206 citations · Cited by this paper

Source: OpenAlex (CC0)